EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Combination of GABA-derived short peptides and pregabalin in neuropathic pain: In vivo and in silico evaluation

Naira H Adamyan, Arusyak G Zhamharyan, Hakob V Topchyan, Tigran K Davtyan, Varduhi H Poghosyan, Knarik M Shamilyan, Sona H Grigoryan, Anush G Tananyan, Maria K Verdyan, Alisa A Chitchiyan, Marine G Balasanyan iD

Molecular Pain · 2026-06 · 22

DOI: 10.1177/17448069261456865 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pain, online erschienen am 26.05.2026. Verfasst von Naira H Adamyan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Yerevan State Medical University After M Heratsi, Yerevan, Armenia. Hauptthemen laut MEDLINE: Pregabalin, Neuralgia, gamma-Aminobutyric Acid, Peptides. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuropathic pain is a significant clinical issue due to the limited efficacy and adverse effects of existing therapies. This study evaluated the antinociceptive effects of the GABA-derived short peptides pyroglutamylGABA, pyroglutamylGABA ethyl ester, and pyroglutamyl diGABA in combination with pregabalin in a rat model of neuropathic pain induced by chronic constriction injury. Pain-related behavior was assessed using the hot plate test by recording changes in the latency and frequency of licking, jumping, and locomotor activity. Co-administration of peptide–pregabalin combinations modulated nociceptive responses compared with control animals in a time- and compound-dependent manner. The combination of pyroglutamylGABA with pregabalin was associated with increased licking latency and reduced licking frequency, particularly at early time points after injury. The pyroglutamylGABA ethyl ester–pregabalin combination produced the most pronounced effects on jumping-related parameters. A delay in movements was recorded when a combination of pyroglutamyl diGABA and pregabalin was used, whereas all combinations demonstrated increased locomotor activity, suggesting that the antinociceptive effects were not accompanied by the motor suppression typically associated with pregabalin treatment. To explore the potential mechanisms, molecular docking studies were performed targeting key GABAergic system components, including the GAT1 transporter, GABA-AT enzyme, and GABA-B receptors. The investigated peptides demonstrated favorable binding affinities across these targets, suggesting that potential interactions with multiple targets are involved in GABAergic neurotransmission. These findings indicate that the combinations of GABA-derived peptides with pregabalin could be an effective approach in neuropathic pain management. However, further investigation is required to validate these effects and clarify the underlying mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PregabalinNeuralgiagamma-Aminobutyric AcidPeptidesComputer SimulationAnimalsMaleMolecular Docking SimulationAnalgesicsRatsMotor ActivityRats, Sprague-DawleyDisease Models, Animal

Stichwörter der Autor:innen

GABAergic systemNeuropathic painanalgesiachronic constriction injurycombination therapymolecular dockingshort peptides

Substanzen

Pregabalingamma-Aminobutyric AcidAnalgesicsPeptides

Autor:innen und Institutionen

  • Department of Pharmacology, Yerevan State Medical University After M Heratsi, Yerevan, Armenia.
  • Department of Pharmacy, Yerevan State Medical University After M Heratsi, Yerevan, Armenia.
  • Department of Drug Technology, Yerevan State Medical University After M Heratsi, Yerevan, Armenia.
  • Laboratory of Immunology and Virology, OOO Armenikum, Yerevan, Armenia.

ORCID-Profile: Marine G Balasanyan

Zitieren

APA

Adamyan, N. H., Zhamharyan, A. G., Topchyan, H. V., Davtyan, T. K., Poghosyan, V. H., Shamilyan, K. M., Grigoryan, S. H., Tananyan, A. G., Verdyan, M. K., Chitchiyan, A. A., & Balasanyan, M. G. (2026). Combination of GABA-derived short peptides and pregabalin in neuropathic pain: In vivo and in silico evaluation. Molecular Pain, 22. https://doi.org/10.1177/17448069261456865

Vancouver

Adamyan NH, Zhamharyan AG, Topchyan HV, Davtyan TK, Poghosyan VH, Shamilyan KM, et al. Combination of GABA-derived short peptides and pregabalin in neuropathic pain: In vivo and in silico evaluation. Molecular Pain. 2026;22. doi:10.1177/17448069261456865

BibTeX
@article{Adamyan2026,
  author = {Adamyan, Naira H and Zhamharyan, Arusyak G and Topchyan, Hakob V and Davtyan, Tigran K and Poghosyan, Varduhi H and Shamilyan, Knarik M and Grigoryan, Sona H and Tananyan, Anush G and Verdyan, Maria K and Chitchiyan, Alisa A and Balasanyan, Marine G},
  title = {Combination of GABA-derived short peptides and pregabalin in neuropathic pain: In vivo and in silico evaluation},
  journal = {Molecular Pain},
  year = {2026},
  volume = {22},
  doi = {10.1177/17448069261456865}
}
Kostenlos starten →